Literature DB >> 21309487

High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia.

Y Li1, J Liu, C Yuan, B Cui, X Zou, Y Qiao.   

Abstract

This study was designed to investigate whether there is a correlation between the down-regulation of microRNA-218 (miR-218) and the presence of human papillomavirus (HPV) infection in the pathogenesis of cervical cancer. The participants comprised 78 women with cervical intraepithelial neoplasia (CIN); 22 (28.2%) had CIN 1, 27 (34.6%) had CIN 2 and 29 (37.2%) had CIN 3. MiR-218 expression was determined by reverse transcriptase polymerase chain reaction and HPV genotypes in tissue specimens were identified with a microarray test kit. The findings showed that miR-218 levels in patients with high-risk HPV infection were lower than in those infected with low-risk or intermediate-risk HPV, or in those who were HPV-free. MiR-218 levels in patients with high-risk CIN were lower than in those with low-risk CIN. We concluded that infection with high-risk HPV lowered the expression of miR-218 and that down-regulation of miR-218 was involved in the pathogenesis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21309487     DOI: 10.1177/147323001003800518

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  19 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

Review 2.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

3.  Preliminary analysis of different microRNA expression levels in juvenile angiofibromas.

Authors:  Cornelia Lerner; Silke Wemmert; Bernhard Schick
Journal:  Biomed Rep       Date:  2014-08-19

Review 4.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

Review 5.  Smoking and microRNA dysregulation: a cancerous combination.

Authors:  Navneet Momi; Sukhwinder Kaur; Satyanarayana Rachagani; Apar K Ganti; Surinder K Batra
Journal:  Trends Mol Med       Date:  2013-11-13       Impact factor: 11.951

Review 6.  Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.

Authors:  Maria Lina Tornesello; Luigi Buonaguro; Paolo Giorgi-Rossi; Franco M Buonaguro
Journal:  Biomed Res Int       Date:  2013-12-09       Impact factor: 3.411

7.  Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells.

Authors:  Jiarong Zhang; Shuangdi Li; Qin Yan; Xiaoyue Chen; Yixia Yang; Xuelian Liu; Xiaoping Wan
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes.

Authors:  Talha Abdul Halim; Ammad Ahmad Farooqi; Farrukh Zaman
Journal:  Cancer Cell Int       Date:  2013-06-17       Impact factor: 5.722

9.  A pri-miR-218 variant and risk of cervical carcinoma in Chinese women.

Authors:  Ting-Yan Shi; Xiao-Jun Chen; Mei-Ling Zhu; Meng-Yun Wang; Jing He; Ke-Da Yu; Zhi-Ming Shao; Meng-Hong Sun; Xiao-Yan Zhou; Xi Cheng; Xiaohua Wu; Qingyi Wei
Journal:  BMC Cancer       Date:  2013-01-15       Impact factor: 4.430

10.  Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.

Authors:  Noriko Yamamoto; Takashi Kinoshita; Nijiro Nohata; Toshihiko Itesako; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Naohiko Seki
Journal:  Int J Oncol       Date:  2013-03-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.